We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$777M
AUM Growth
-$10.7M
Cap. Flow
-$2.88M
Cap. Flow %
-0.37%
Top 10 Hldgs %
22.01%
Holding
267
New
2
Increased
69
Reduced
89
Closed
10

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$1.46M
2
AGN
Allergan plc
AGN
+$662K
3
DIS icon
Walt Disney
DIS
+$472K
4
WY icon
Weyerhaeuser
WY
+$319K
5
ATW
Atwood Oceanics
ATW
+$311K

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$2.13M
2
FRX
FOREST LABORATORIES INC
FRX
+$880K
3
ABBV icon
AbbVie
ABBV
+$539K
4
NLSN
Nielsen Holdings plc
NLSN
+$388K
5
GXC icon
State Street SPDR S&P China ETF
GXC
+$361K

Sector Composition

Rank Sector Weight
1 Healthcare 18.02%
2 Miscellaneous 14.73%
3 Industrials 14.1%
4 Technology 12.24%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DD
51
DELISTED
Du Pont De Nemours E I
DD
$4.94M 0.64%
72,527
-1,685
-2% -$106K
VEA icon
52
Vanguard FTSE Developed Markets ETF
VEA
$233B
$4.54M 0.58%
114,204
+805
+0.7% +$33.5K
VZ icon
53
Verizon
VZ
$214B
$4.51M 0.58%
90,196
+29,311
+48% +$1.46M
ABT icon
54
Abbott
ABT
$177B
$4.33M 0.56%
104,125
-452
-0.4% -$19.1K
XRAY icon
55
Dentsply Sirona
XRAY
$1.99B
$4.32M 0.56%
94,659
-420
-0.4% -$19.8K
NVS icon
56
Novartis
NVS
$264B
$4.26M 0.55%
50,517
+17
+0% +$1.38K
KO icon
57
Coca-Cola
KO
$381B
$4.25M 0.55%
99,683
-1,240
-1% -$51.3K
QQQ icon
58
Invesco QQQ Trust
QQQ
$474B
$4.23M 0.54%
42,803
+2,025
+5% +$197K
LKQ icon
59
LKQ Corp
LKQ
$6.08B
$4.21M 0.54%
158,335
+1,800
+1% +$48.4K
WAB icon
60
Wabtec
WAB
$46.9B
$4.2M 0.54%
51,785
+150
+0.3% +$12.4K
QCOM icon
61
Qualcomm
QCOM
$202B
$4.18M 0.54%
55,975
+140
+0.3% +$10.7K
PFE icon
62
Pfizer
PFE
$157B
$4.17M 0.54%
148,592
-2,010
-1% -$56.4K
BEN icon
63
Franklin Templeton
BEN
$16.8B
$4.17M 0.54%
76,270
-184
-0.2% -$10.3K
AL
64
DELISTED
Air Lease Corp
AL
$4.16M 0.54%
127,969
+2,960
+2% +$108K
ADP icon
65
Automatic Data Processing
ADP
$110B
$3.96M 0.51%
54,308
-683
-1% -$49.3K
CL icon
66
Colgate-Palmolive
CL
$69.7B
$3.96M 0.51%
60,644
+3,450
+6% +$228K
LECO icon
67
Lincoln Electric
LECO
$13.8B
$3.81M 0.49%
55,073
+249
+0.5% +$17.3K
CVS icon
68
CVS Health
CVS
$121B
$3.75M 0.48%
47,121
+223
+0.5% +$17.6K
MKC icon
69
McCormick & Company Non-Voting
MKC
$13.5B
$3.75M 0.48%
112,120
-150
-0.1% -$5.16K
AMZN icon
70
Amazon
AMZN
$2.68T
$3.71M 0.48%
230,120
+100
+0% +$1.66K
CSCO icon
71
Cisco
CSCO
$433B
$3.56M 0.46%
141,332
-750
-0.5% -$18.9K
MO icon
72
Altria Group
MO
$117B
$3.4M 0.44%
74,071
– –
COP icon
73
ConocoPhillips
COP
$170B
$3.36M 0.43%
43,908
-200
-0.5% -$16.4K
LOW icon
74
Lowe's Companies
LOW
$110B
$3.28M 0.42%
61,974
-700
-1% -$35.4K
BHP icon
75
BHP
BHP
$215B
$3.25M 0.42%
65,194
-1,508
-2% -$87.7K
1 2
3
4 5

Similar funds

MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.65B AUM 184.75% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Boston Family Office's Q3 2014 Portfolio in Review

As of Q3 2014, Boston Family Office held 267 positions worth $777M, down 1.4% from $788M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 4.5%. Boston Family Office opened 2 new positions and exited 10, leaving the 267-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Industrials.

  • Boston Family Office's largest Q3 2014 buy was Allergan plc: 2,957 shares worth $713K.
  • Boston Family Office added most to Verizon in Q3 2014, an estimated $1.46M increase.
  • Boston Family Office's biggest Q3 2014 reduction was AbbVie, cutting an estimated $539K.
  • Boston Family Office fully exited Meridian Bioscience Inc in Q3 2014, selling an estimated $2.13M.
  • Boston Family Office's ten largest holdings make up 22% of its $777M portfolio in Q3 2014.
  • Boston Family Office opened 2 new positions and closed 10 in Q3 2014.
  • Boston Family Office's portfolio value fell 1.4% quarter-over-quarter to $777M.

Based on Boston Family Office's 13F filing for Q3 2014, filed 31 Oct 2014.